ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS SCIE Q4Scopus Q2SCImago #9,490Gold OA

Journal of Tissue Engineering and Regenerative Medicine

Acronym:term
•
Abbreviation (ISO):J. TISSUE ENG. REGENER. MED
•
Identifier (ISSN):1932-6254(Print)/1932-7005(Online)
•
Publisher:John Wiley and Sons Ltd
Clarivate IF (2026)
2↓ -0.6
Journal Impact Factor
IF Trend↓
WoS Quartile
Q4
WoS SCIEJCR Quartile
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Journal of Tissue Engineering and Regenerative Medicine

WoS Q4
13464.0920183.3220193.0820203.9620214.3220223.320233.120242.6202522026
Annual Impact Factor Metric
Current (2026):2
Scopus SJR & RankScopus Q2
0.62
#9,490

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
101

101 papers with at least that number of citations each

WoS: SCIE / JCRQ4
Self-Citation Rate3.2%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessGold OA
94articles/year
100% Gold OA•82.67% Original Research

Aims & Scope

Journal of Tissue Engineering and Regenerative Medicine publishes rapidly and rigorously peer-reviewed research papers, reviews, clinical case reports, perspectives, and short communications on topics relevant to the development of therapeutic approaches which combine stem or progenitor cells, biomaterials and scaffolds, growth factors and other bioactive agents, and their respective constructs. All papers should deal with research that has a direct or potential impact on the development of novel clinical approaches for the regeneration or repair of tissues and organs. The journal is multidisciplinary, covering the combination of the principles of life sciences and engineering in efforts to advance medicine and clinical strategies. The journal focuses on the use of cells, materials, and biochemical/mechanical factors in the development of biological functional substitutes that restore, maintain, or improve tissue or organ function. The journal publishes research on any tissue or organ and covers all key aspects of the field, including the development of new biomaterials and processing of scaffolds; the use of different types of cells (mainly stem and progenitor cells) and their culture in specific bioreactors; studies in relevant animal models; and clinical trials in human patients performed under strict regulatory and ethical frameworks. Manuscripts describing the use of advanced methods for the characterization of engineered tissues are also of special interest to the journal readership.

Topics Covered (Recognized by AI)
Biology85.5%Medicine82.9%Chemistry80.1%Genetics78.9%Biochemistry68.3%Cell biology63.7%Engineering58.3%Internal medicine52.4%Biomedical engineering52%Pathology50.2%Computer science39.4%In vitro37.3%Materials science36.6%Anatomy33.4%Organic chemistry33%Tissue engineering31.7%Physics30.2%Stem cell30%Cell27.5%Immunology27.2%Surgery26.7%Mesenchymal stem cell25.6%Endocrinology24.3%Composite material22.3%Gene22.2%
Primary Research Areas

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRSCIE2026

BIOTECHNOLOGY & APPLIED MICROBIOLOGY

Q4
Rank137/180
IndexSCIE
JCRSCIE2026

CELL & TISSUE ENGINEERING

Q4
Rank27/32
IndexSCIE
JCRSCIE2026

CELL BIOLOGY

Q4
Rank172/207
IndexSCIE
JCRSCIE2026

ENGINEERING, BIOMEDICAL

Q3
Rank94/130
IndexSCIE
JCISCIE2026

BIOTECHNOLOGY & APPLIED MICROBIOLOGY

Q3
Rank121/180
IndexSCIE
JCISCIE2026

CELL & TISSUE ENGINEERING

Q3
Rank22/32
IndexSCIE
JCISCIE2026

CELL BIOLOGY

Q3
Rank142/207
IndexSCIE
JCISCIE2026

ENGINEERING, BIOMEDICAL

Q3
Rank83/130
IndexSCIE

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
2026Latest
IF2
Articles / Year5
Total Citations0
2025
IF2.6
Articles / Year22
Total Citations40
2024
IF3.1
Articles / Year13
Total Citations58
2023
IF3.3
Articles / Year37
Total Citations188
2022
IF4.323
Articles / Year101
Total Citations1,255

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #9,490Scopus Q2SCImago Profile
Scopus Coverage:2006-2026
Scopus Broad Areas:EngineeringMaterials ScienceMedicine
Scopus Citation Rank (SJR)Q2
0.62

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q2
Citations / Doc (2 years)
1.76

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$3,082 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations449
3-Year Documents147
Citable Documents147

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate52.3%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Biomedical EngineeringQ2
Medicine (miscellaneous)Q2
BiomaterialsQ3
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 3.2%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
3区 (Zone 3)Medicine
Minor Category (Specific Field):
4区CELL & TISSUE ENGINEERING
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Journal of Tissue Engineering and Regenerative Medicine (acronym: term, abbr: J. TISSUE ENG. REGENER. MED, ISSN: 1932-6254) is a peer-reviewed international scholarly journal in the field of Biology, published by John Wiley and Sons Ltd in England since 2007. The periodical holds a Journal Impact Factor (JIF) of 2.00, ranking in quartile Q4 of Web of Science (SCIE), a Scopus SJR indicator of 0.620 (Q2), an H-index of 101.

The journal enforces rigorous peer evaluation with a publication frequency of Bimonthly, an annual output of approximately 94 scientific articles. In terms of accessibility and author fees, it operates under the Gold OA model with an estimated APC of $3,082 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Gold OA
Publisher
John Wiley and Sons Ltd
Publication Language
English
Frequency
Bimonthly
Founding Year
2007
Indexing & Databases
SCIEScopusPubMed
Editorial Address
JOHN WILEY & SONS LTD, THE ATRIUM, SOUTHERN GATE, CHICHESTER, ENGLAND, W SUSSEX, PO19 8SQ

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: bf86ed22-b32d-47b3-bcc0-8fe844787351
Database Updated: 2026-10-01